Bactericidal power of human serum after massive irradiation.

Bactericidal power of human serum after massive irradiation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Bactericidal power of human serum after massive irradiation. Abstract Text:

Bactericidal power of human serum after massive irradiation. Publishing Authors By Initials

For similar disorders of environmental origin: wounds and injuries: radiation injuries research abstracts see: disorders of environmental origin: wounds and injuries: radiation injuries research

PUBMED ID PMID:

MEDLINE DATE:

Bactericidal power of human serum after massive irradiation. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: ORINS [reports]. U.S. Atomic Energy Commission

VOLUME: ORINS-25

Page Numbers: 8-1

Journal Abbreviation:

ISSN:

DAY: 4

MONTH: Apr

YEAR: 1959

Bactericidal power of human serum after massive irradiation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 21830620

Bactericidal power of human serum after massive irradiation. Keywords Mesh Terms:

KEYWORDS: Radiation Injuries

MESH TERMS: immunology

Chemical & Substance for Abstract: Bactericidal power of human serum after massive irradiation. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Bactericidal power of human serum after massive irradiation.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: ORINS Rep US At Energy Comm

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Bactericidal power of human serum after massive irradiation Related Publications

• A piece of my mind. In the here and now.
• Acute and chronic megacolon.
• Appropriate use of laxatives in the management of constipation.
• Basic factors in the spectral sensitivity of human vision.
• Continuous monitoring of dynamic pulmonary compliance enables detection of endobronchial intubation in infants and children.
• Degenerate mode band-pass birdcage coil for accelerated parallel excitation.
• Diagnostics for herpes simplex virus: is PCR the new gold standard?
• Does this child have a urinary tract infection?
• Dose requirements among hemodialysis patients treated with darbepoetin-alpha or epoetin-beta.
• Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes.
• Ethics and standards in clinical engineering.
• Exploring a Boeing 777: ray tracing large-scale CAD data.
• Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
• Familial hypercholesterolaemia: screening needs a fresh approach.
• Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men.
• Fresh perspectives in chronic constipation and other functional bowel disorders.
• Genital herpes.
• HSV-2 serologic testing in an HMO population: uptake and psychosocial sequelae.
• Involvement of growth factors in the process of post-vasectomy micro-recanalization.
• Noise induced hearing loss and leisure activities of young people: a pilot study.
• Oral antibiotics are effective for pyelonephritis in children.
• Phase maps reveal cortical architecture.
• Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection.
• Prenatal herpes simplex virus serologic screening beliefs and practices among obstetricians.
• Screening: a step too far. A matter of concern.
• Studying injury prevention: practices, problems, and pitfalls in implementation.
• The effect of correlations between screening markers on screening performance.
• The photochemistry of vision.
• The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma.
• Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.